Outset Medical plans to begin shipping the updated platform during the second quarter of 2026.

Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.

The next-generation Tablo platform is expected to begin shipping to customers in the second quarter of 2026. Healthcare providers currently using Tablo will be eligible to upgrade to the new ...

Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt In addition, Outset has entered into a credit agreement and guaranty with a fund managed by ...

Revenue for 2025 is projected to be between $115 million and $125 million, with expectations of console growth and recurring revenue expansion. Gross margins for 2025 are expected to be in the high 30 ...

Outset Medical, Inc. OM shares ended the last trading session 22.2% higher at $5.57. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...

Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...

Outset Medical, Inc. (Nasdaq: OM) ('Outset”), a medical technology company pioneering a first-of-its-kind technology to ...

Outset Medical, Inc. has appointed Renee Gaeta as its new Chief Financial Officer, effective immediately, succeeding Nabeel Ahmed who is leaving for other opportunities. Gaeta brings extensive ...

Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research ...

Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...